Movicol and Hyperkinesia - a phase IV clinical study of FDA data

Summary:

Hyperkinesia is reported as a side effect among people who take Movicol (polyethylene glycol 3350), especially for people who are male, 60+ old, also take Vitamin B12, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Hyperkinesia when taking Movicol. It is created by eHealthMe based on reports of 14,199 people who have side effects when taking Movicol from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Hyperkinesia?

Hyperkinesia (higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs) is found to be associated with 211 drugs and 315 conditions by eHealthMe. Check the latest studies of Hyperkinesia.

On Jul, 17, 2026

14,199 people reported to have side effects when taking Movicol.
Among them, 73 people (0.51%) have Hyperkinesia.

Among these 73 people:

What is the gender of people who have Hyperkinesia when taking Movicol? *

female: 41.67 %
male: 58.33 %

What is the age of people who have Hyperkinesia when taking Movicol? *

What are other drugs people take besides Movicol? *

What are other side effects people have besides Hyperkinesia? *

Fall: 26 people, 35.62%
Parkinson's Disease: 20 people, 27.40%
Mobility Decreased (ability to move is reduced): 18 people, 24.66%
Akinesia (loss of control of voluntary muscle movements): 17 people, 23.29%
On And Off Phenomenon: 14 people, 19.18%
Dyskinesia (abnormality or impairment of voluntary movement): 13 people, 17.81%
Hallucinations (sensations that appear real but are created by your mind): 10 people, 13.70%
Agitation (state of anxiety or nervous excitement): 10 people, 13.70%
Psychotic Disorder: 10 people, 13.70%
General Physical Health Deterioration (weak health status): 9 people, 12.33%

What are the existing conditions these people have? *

Parkinson's Disease: 73 people, 100.00%
Abdominal Distension: 6 people, 8.22%
Sleep Disorder: 2 people, 2.74%
Pain: 2 people, 2.74%
Depression: 2 people, 2.74%
Type 2 Diabetes: 1 person, 1.37%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 1 person, 1.37%
Pain In Extremity: 1 person, 1.37%
Joint Pain: 1 person, 1.37%
High Blood Pressure: 1 person, 1.37%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and have Hyperkinesia?

- Check whether Hyperkinesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Movicol:

Movicol (14,249 reports)

Hyperkinesia treatments and more:

Hyperkinesia (2,748 reports)

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkinesia:

Hyperkinesia (211 drugs)

Browse all the conditions that are associated with Hyperkinesia:

Hyperkinesia (315 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Movicol) and Movicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.